In this interactive case challenge make clinical decisions to guide treatment of a young patient newly diagnosed with schizophrenia from inpatient discharge into communitybased care This patient journey requires knowledge of available longacting injectable LAI antipsychotic formulations and dosing equivalencies as well as communication points on benefits of LAI treatment and patient preferences for administration
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/psychiatry/lai-icc1-2024/25078-56935
- Start Date: 2024-10-18 05:00:00
- End Date: 2024-10-18 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Indivior Inc - Amount: 2272.72 - Is Kind Support: False Source: Otsuka America Pharmaceutical, Inc. - Amount: 454.45 - Is Kind Support: False Source: Teva Pharmaceutical Industries - Amount: 22727.27 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest